Edwards Intuity surgical aortic valve nets CE Mark

Justine Varieur Cadet | | Health Imaging | Diagnostic Imaging
Edwards Lifesciences, a developer of heart valves and hemodynamic monitoring systems, has received CE Mark in Europe for its Edwards Intuity valve system for use in patients undergoing surgical aortic valve replacement (AVR).

The system, which consists of a bovine pericardial heart valve and delivery system, facilitates small incision surgery and valve deployment during AVR procedures. The company plans to begin a European launch at centers participating in post-approval clinical studies. Edwards Intuity leverages the design of Edwards' pericardial valve technology, featuring a balloon-expandable frame designed to facilitate annular placement.

The Edwards Intuity valve system is not yet available for sale or use in the U.S.

Justine Varieur Cadet

Related Content

AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?
Speaker laments radiology’s major contribution to climate change
Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.